Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Cost of Revenue (2022 - 2025)

Cardio Diagnostics Holdings' Cost of Revenue history spans 4 years, with the latest figure at $41820.0 for Q1 2025.

  • For Q1 2025, Cost of Revenue rose 21.56% year-over-year to $41820.0; the TTM value through Mar 2025 reached $189864.0, up 32.43%, while the annual FY2024 figure was $182446.0, 15.1% up from the prior year.
  • Cost of Revenue for Q1 2025 was $41820.0 at Cardio Diagnostics Holdings, up from $38206.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $57779.0 in Q2 2024 and bottomed at $16369.0 in Q3 2022.
  • The 4-year median for Cost of Revenue is $34402.0 (2024), against an average of $36575.4.
  • The largest annual shift saw Cost of Revenue surged 121.23% in 2023 before it tumbled 30.57% in 2024.
  • A 4-year view of Cost of Revenue shows it stood at $27127.0 in 2022, then soared by 59.58% to $43288.0 in 2023, then dropped by 11.74% to $38206.0 in 2024, then rose by 9.46% to $41820.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Cost of Revenue are $41820.0 (Q1 2025), $38206.0 (Q4 2024), and $52059.0 (Q3 2024).